Inovio Pharmaceuticals (0A43.LSE) Q2 2024 Earnings

13MayConfirmed
Q4 2023
Q2 2024
-1.31
-1.21
-1.11
-1.01

Details

Expected EPS
-1.013333
Actual EPS
-1.31
Surprise EPS
-0.3
Surprise Percent
+29.28%

Description

Inovio Pharmaceuticals (0A43.LSE) has reported earnings of -1.31 per share for Q2 2024.

0 Comments

Share your thoughts